Department of Renal Medicine, Royal Derby Hospital
Derby, Derbyshire, DE22 3NE, United Kingdom
NCT Number: NCT05700851
The purpose of this pilot study is to test if an "immuno-nutrition" supplement can decrease inflammation in people on haemodialysis. This immuno-nutrition supplement is high in calories and protein like other common nutritional supplements, but also contains a unique combination of ingredients that have been shown to reduce inflammation (a problem which is caused by the body's defence [immune] system communicating that something is wrong) and improve the immune system in people with cancer. The research team hopes that this small study will help with gaining a good understanding of the effect of immuno-nutrition on inflammation in people on haemodialysis, which will guide and allow the research team to do a larger research study in the future.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Derby, Derbyshire, DE22 3NE, United Kingdom
Participants will be asked to take one sachet of the immuno-nutrition supplement each day for 6 weeks. The renal dietitian on the research team will provide participants with detailed oral advice on how and when to take the immuno-nutrition supplement.
Participants will need to complete 3-day food diaries at the beginning, mid-way point and end of the study.
The research team will measure weight, height, handgrip strength (a measure of muscle strength), body's composition of fat and muscle using a specialist scale, and skin autofluorescence levels (a measure of toxins called advanced glycation end-products).
The research team will collect the results of routine blood tests. The research team will also collect and store blood samples taken before and after a haemodialysis session to measure some molecules that indicate inflammation.
All of these measurements and samples will be taken at the start of the study, and after 6 weeks of taking the immuno-nutrition supplement.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Oral Impact® is a powdered oral nutritional supplement that contains a unique combination of ingredients with immuno-modulating properties, namely omega-3 fatty acids, arginine and nucleotides, as well as soluble fibre.
Other names: Oral Impact®, Nestlé
Time frame: 6 weeks
C reactive protein levels in mg/L using a high-sensitive laboratory test
Time frame: 6 weeks
Interleukin-6 levels in pg/ml using enzyme-linked immunosorbent assay
Time frame: 6 weeks
Interleukin-8 levels in pg/ml using enzyme-linked immunosorbent assay
Time frame: 6 weeks
Skeletal muscle mass in kg assessed with the InBody 770 Multi-Frequency Bioimpedance Analysis equipment.
Time frame: 6 weeks
Energy intake in kcal/kg of body weight/day assessed with 3-day food diaries and analysed using the diet software Nutritics
Time frame: 6 weeks
Protein intake in g/kg of body weight/day assessed with 3-day food diaries and analysed using the diet software Nutritics
Time frame: 6 weeks
Handgrip strength in kg measured with the Takei 5401 handgrip digital dynamometer
University of Nottingham
Other
Effect of Immuno-nutrition on Systemic Inflammation in People Receiving Haemodialysis: a Pilot Study
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT03535922
Chronic Disease, Chronic Kidney Disease Requiring Chronic Dialysis
Calgary, Alberta, Canada
View Trial DetailsNCT05209880
Cardiovascular Diseases, Chronic Disease
Boston, Massachusetts, United States
View Trial DetailsNCT07030465
Chronic Kidney Disease Requiring Chronic Dialysis
Jakarta Pusat, DKI Jakarta, Indonesia
View Trial DetailsNCT05086185
Chronic Disease, Chronic Kidney Disease Requiring Chronic Dialysis
Reno, Nevada, United States
View Trial Details